Last week, we had the great pleasure of interviewing Liza Velarde, the cofounder and acting CEO of Delee. Founded in 2017, Delee has developed an innovative medical device that allows early diagnoses of cancer and treatment monitoring.
Delee was a part of the winter 2017 Y combinator cohort and is currently running a Republic crowdfunding campaign. Delee is doing exceptional work in medical technology and is fundamentally changing the way cancer is detected and treated.
Liza Shares:
β Advice for other founders
β An incredible video presentation sharing Deleeβs early cancer detection testing
Join us for a http://www.founderspack.io pitch event and sign up for the free Startup & Grow course FOLLOW US ON STONKS: https://stonks.com/founders-pack